DP V Associates LP

This profile gathers the share dealings of DP V Associates LP across 5 companies, led by REVA Medical, Inc., Paratek Pharmaceuticals, Inc. and Orexigen Therapeutics, Inc. In total, 26 filings cover trades dated from 6 February 2006 to 23 March 2012.

In open-market terms, that means 3 purchases worth €268k on one side and 10 sales worth €1.4M on the other. On balance, insiders were net sellers of €1.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants. So far in 2012, the count stands at no purchases and 1 sale.

Half of the purchases are above €107k and half below.

The newest entry dates from 27 March 2012: an open-market sale of €153k, in REVA Medical, Inc. The last insider purchase was made public on 1 May 2007, 7,132 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.